Literature DB >> 20304176

Portal vein thrombosis and liver transplantation: long term.

A P Ramos1, C P H Reigada, E C Ataíde, J R S Almeida, A R Cardoso, C A Caruy, R S B Stucchi, I F S F Boin.   

Abstract

Obstruction of the portal vein may be related to constriction by malignant tumors or thrombosis associated with liver disease. We herein have reported our experience with patients undergoing liver transplantation with portal vein thrombosis (PVT) whose diagnosis was made intraoperatively. From September 1991 to May 2009, we studied 27/419 (6.4%) patients with PVT who were evaluated according to the presence of esophagogastric varices, underlying disease, malignancy, and if there was previous surgery, review of medical records on data collected prospectively. We observed 24 (88.9%) patients with PVT grade 1, 2 (7.4%) with grade 2, and 1 (3.7%) with grade 3. The average age of the PVT patients was 47.5 years; the average model for End-Stage Liver Discase score was 18.3, and the predominant diagnosis, hepatitis C cirrhosis. Eighteen underwent a sclerotherapy/ligature. The sensitivity of ultrasound for grade 1 thrombosis was 39.1%; for grade 2, 50%; and for grade 3, 100%. Portal vein thrombectomy was performed in 24 patients. In other patients (grade 2), we performed an anastomosis of the donor portal vein to the recipient gastric vein or to a greater splanchnic collateral vein. In only 1 patient was the graft performed using the donor portal vein-donor iliac vein-recipient superior mesenteric vein. None of the patients displayed PVT in the immediate postoperative period. Actuarial survivals at the years 1, 3, and 5 were 85%, 74%, and 63%, respectively. We concluded that PVT cannot be considered to be a contraindication for liver transplantation. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20304176     DOI: 10.1016/j.transproceed.2010.01.038

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  An early single-center experience of portal vein thrombosis in living donor liver transplantation: clinical feature, management and outcome.

Authors:  Joo Dong Kim; Dong Lak Choi; Young Seok Han
Journal:  J Korean Surg Soc       Date:  2011-07-11

2.  Management of complications after varicoportal anastomosis in liver transplantation.

Authors:  Daniela Kniepeiss; Helmut Müller; Doris Wagner; Florian Iberer; Karl-Heinz Tscheliessnigg
Journal:  Wien Klin Wochenschr       Date:  2011-05-31       Impact factor: 1.704

3.  Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization.

Authors:  Wei Lai; Shi-Chun Lu; Guan-Yin Li; Chuan-Yun Li; Ju-Shan Wu; Qing-Liang Guo; Meng-Long Wang; Ning Li
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

Review 4.  Portal vein thrombosis in liver cirrhosis.

Authors:  Nao Kinjo; Hirofumi Kawanaka; Tomohiko Akahoshi; Yoshihiro Matsumoto; Masahiro Kamori; Yoshihiro Nagao; Naotaka Hashimoto; Hideo Uehara; Morimasa Tomikawa; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Hepatol       Date:  2014-02-27

5.  A comparative study of two anti-coagulation plans on the prevention of PVST after laparoscopic splenectomy and esophagogastric devascularization.

Authors:  Zhe Cheng; Fan Yu; Ju Tian; Peng Guo; Jianwei Li; Jian Chen; Yudong Fan; Shuguo Zheng
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

Review 6.  Portal vein thrombosis: should anticoagulation be used?

Authors:  Stephen E Congly; Samuel S Lee
Journal:  Curr Gastroenterol Rep       Date:  2013-02

7.  D-dimer level in liver transplant recipients on the first day after surgery is correlated with postoperative thrombosis recurrence.

Authors:  Qun Zhang; Renyong Guo; Yu Chen
Journal:  J Clin Lab Anal       Date:  2018-08-13       Impact factor: 2.352

8.  Short-Term Outcome of Patients with Cirrhosis and Concurrent Portal Cavernoma Presenting with Acute Variceal Bleeding.

Authors:  Xuefeng Luo; Wanqin Wang; Xiaoli Fan; Ying Zhao; Xiaoze Wang; Jinlin Yang; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.